INCY vs XBIT · P/E 14, rev $5.14B vs $83.8M cap
Incyte Corporation (INCY) versus XBiotech Inc (XBIT) — a side-by-side from cached financials, not a winner call.
Incyte Corporation (INCY) is a biotechnology company listed on US.
XBiotech Inc (XBIT) is a biotechnology company listed on US.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
XBIT does not have a complete income-statement cache yet.
INCY currently screens at market cap $20.45B and trailing P/E 14.5. XBIT currently screens at market cap $83.8M.
Not investment advice. Open the INCY and XBIT stock pages for the full models.
Not investment advice.